Retraction

A Cytoplasm-Enriched circRNA circ-MYBL2 is Downregulated in Non-Small Cell Lung Cancer and Sponges Oncogenic miR-28 to Regulate Cancer Cell Proliferation and Apoptosis

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.2147/CMAR.S348920

Citations (6)

6
Total Citations
5
Post-Retraction
(83.3%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
2 After 2+ years
1290 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
miR-28: A Tiny Player in Cancer Progression and Other Human Diseases
Karol Kotarski, Marta Kot, Klaudia Skrzypek
Biomolecules Open Access
Published: May 2025
1290 days after retraction
Exosome‐transported circ_0001955 as a potent driver of breast cancer by regulating the <scp>miR</scp>‐708‐5p/<scp>PGK1</scp> axis
Wenxin Li, Gaowa Jin, He Zhou et al. (6 authors)
Thoracic Cancer Open Access
Published: Oct 2024
1 citation
1083 days after retraction
The importance of hsa-miR-28 in human malignancies
Seyede Fatemeh Hosseini, Setareh Javanshir-giv, Hanieh Soleimani et al. (6 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Mar 2023
8 citations
475 days after retraction
hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis
Fangfang Yang, Yanli Pei, Wei Xu et al. (4 authors)
Disease Markers Open Access
Published: Sep 2022
8 citations
316 days after retraction
[High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Ming Yang, Xiaodan Zhu, Yang Shen et al. (8 authors)
PubMed
Published: Aug 2022
282 days after retraction
Quick Stats
Total Citations: 8
Years Since Retraction: 4.0 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers